Correlation of Serum Parathyroid hormone, Serum Osteocalcin and Serum Tartrate resistant acid Phosphatase (TRACP) 5b with Bone mineral disease in Chronic Kidney Disease patients
DOI:
https://doi.org/10.48047/v9rx2t15Keywords:
Parathyroid hormone, Osteocalcin, (TRACP) 5b, Bone mineral disease, Chronic kidney disease.Abstract
Introduction: CKD is a major cause of fatality in India as described as kidney damage or decreased kidney function for three months or longer, regardless of the cause. The retention of phosphorus decreases the levels of calcitriol within the parathyroid gland that give rise to increased iPTH secretion as well as increased parathyroid growth, skeletal resistance towards iPTH and hypocalcaemia. Also Serum osteocalcin levels provide a non-invasive marker of osteoblast activity and bone formation. Also Tartrate-resistant acid phosphatase (TRACP) 5b is secreted into the circulation from osteoclasts during bone resorption and has been proposed as a bone resorption marker with an increased serum level that is independent of renal dysfunction.
Downloads
References
Kamimura MA, Avesani CM, Cendoroglo M et al. Comparison of skin fold thicknesses and bioelectrical impedance analysis with dual energy X-ray
absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant. 2003; 18:101–5. 2. Carrero JJ, Stenvinkel P et al. Inflammation in end- stage renal disease--what have we learned in 10 years 2010 Sep-Oct;23(5):498-509.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.